Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from ecancermedicalscience

11:29 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "ecancermedicalscience" found in our extensive news archives from over 250 global news sources.

More Information about ecancermedicalscience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ecancermedicalscience for you to read. Along with our medical data and news we also list ecancermedicalscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of ecancermedicalscience Companies for you to search.

Showing News Articles 1–25 of 1,200+ from ecancermedicalscience

Thursday 13th December 2018

The evolution of advanced non-small cell lung cancer treatment: Is long-term survival possible in the squamous cell patient population?

SPONSORED CONTENT Alastair Greystoke Senior Lecturer and Honorary Consultant in Medical Oncology, Newcastle University and the Northern Centre for Cancer Care, Newcastle, UK Acknowledgements: Bristol-Myers Squibb Pharmaceuticals Limited has had full...

Wednesday 12th December 2018

Accelerated partial breast irradiation not equivalent to whole breast irradiation

Dr Frank Vicini gives a press conference at SABCS 2018 about the results from the NRG trial, which indicated that accelerated partial breast irradiation was not equivalent to whole breast irradiation in patients with ipsilateral breast tumour...

Circulating tumour-cell count used to decide between treatments for breast cancer patients

Dr Francois-Clement Bidard gives a press conference at SABCS 2018 about the results from the phase III STIC CTC trial, where circulating tumour-cell count was used to decide between hormone therapy or chemotherapy for patients with metastatic, ER , HER2-...

Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer

Prof Emiel Rutgers gives a press conference at SABCS 2018 about the results from the phase III AMAROS clinical trial, where either axillary radiotherapy and axillary lymph node dissection were found to have comparable 10-year recurrence and survival rates...

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients

Dr Miguel Martin gives a press conference at SABCS 2018 about the randomised, phase II GEICAM/CIBOMA trial, which indicated that treating patients with early-stage, triple-negative breast cancer with the chemotherapy agent capecitabine following surgery...

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients

Prof Charles Geyer gives a press conference at SABCS 2018 about the results of the phase III KATHERINE clinical trial, which found that substituting trastuzumab emtansine for adjuvant trastuzumab in improved IDFS in patients with HER2-positive early...

Low-dose tamoxifen reduces recurrence and new breast disease

Prof Andrea De Censi gives a press conference at SABCS 2018 about the results of the phase III TAM-01 clinical trial, where low-dose tamoxifen was found to be safe and effective in reducing recurrence and new breast disease for patients with DCIS, LCIS...

Two clinical trials using combination therapy in adult patients with multiple myeloma

Dr Irene Ghobrial speaks to ecancer at ASH 2018 about two clinical trials for multiple myeloma in adults. The first of these trials was a a Phase Ib/II study of the novel anti-CXCR4 antibody ulocuplumab in combination with lenalidomide plus low-dose...

Tuesday 11th December 2018

New insights into childhood brain cancer tumour growth and regression

Peripheral nervous system tumours are one of the most common types of childhood tumours. While some of these tumours, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment. As...

Some brain tumours may respond to immunotherapy, new study suggests

Immunotherapy has proved effective in treating a number of cancers, but brain tumours have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumour arising in patients affected by neurofibromatosis type 1 (NF1) may be...

Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients

Professors Hope Rugo, Debu Tripathy, Nadia Harbeck and Dr Steven Isakoff meet in San Antonio at the San Antonio Breast Cancer Symposium 2018 annual conference for an educational breast cancer panel discussion. Their talk covers scalp cooling to prevent...

Researchers develop personalised medicine tool for inherited colorectal cancer syndrome

An international team of researchers led by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be...

Monday 10th December 2018

SABCS 2018: Lifestyle intervention helped breast cancer survivors lose weight

Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost weight and experienced higher rates of disease-free survival if they completed the program, according to results presented at the 2018 San Antonio...

SABCS 2018: Oxybutynin decreased frequency of hot flashes, improved QOL for breast cancer survivors

Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement, including breast cancer survivors, according to results of a trial presented at the 2018 San Antonio Breast Cancer...

SABCS 2018: Choice of surgery may affect quality of life for young breast cancer survivors

Even as more young women with breast cancer opt to have mastectomies, many experience a persistent decline in their sexual and psychosocial well-being following the procedure, as detailed in new research by Dana-Farber/Brigham and Women's Cancer...

SABCS 2018: Exercise performed during adjuvant breast cancer treatment may improve cardio function

Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better cardiovascular function than those who were not part of the exercise program, according to results of the EBBA-II trial...

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

Professor Chris Twelves and Dr Giampaolo Bianchini meet in San Antonio at the San Antonio Breast Cancer Symposium 2018 annual conference for an educational breast cancer expert-to-expert discussion. The talk covers the latest data seen for eribulin use in...

Role of chemotherapy in the treatment of metastatic breast cancer patients

Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani meet in San Antonio at the San Antonio Breast Cancer Symposium 2018 annual meeting for an educational breast cancer panel discussion. Their talk covers the role of chemotherapy...

An impassionate conversation on Impassion130: Atezolizumab in combination with nab-paclitaxel in metastatic triple negative breast cancer

Regular ecancer blogger Dr Bishal Gyawali takes a look at the IMpassion130 trial in the form of a conversation between two doctors, A and B:   A: Which is the only drug in cancer history to have its accelerated approval revoked? B: Bevacizumab. A:...

An impassioned conversation on Impassion130: Atezolizumab in combination with nab-paclitaxel in metastatic triple negative breast cancer

Regular ecancer blogger Dr Bishal Gyawali takes a look at the IMpassion130 trial in the form of a conversation between two doctors, A and B:   A: Which is the only drug in cancer history to have its accelerated approval revoked? B: Bevacizumab. A:...

Saturday 8th December 2018

SABCS 2018: Black women have worse breast cancer outcomes despite receiving similar treatment as white women

Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly higher breast cancer recurrence and increased overall mortality compared to white women in a large phase III clinical...

SABCS 2018: Liquid biopsies in SOLAR-1 trial predict benefit of alpelisib in PIK3CA-mutant breast cancer

Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared with analysis of tissue biopsy in breast cancer patients enrolled in the phase III clinical trial SOLAR-1, according to data...

Friday 7th December 2018

SABCS 2018: Axillary radiotherapy and lymph node surgery yielded comparable 10-year outcomes for patients with breast cancer

Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy had comparable 10-year recurrence and survival rates following either axillary radiotherapy or axillary lymph node dissection, according to data from the...

SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients

Circulating tumour-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment for patients with oestrogen receptor-positive (ER ), HER2-negative (HER2-) metastatic breast cancer, according to data from the phase III...

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH

Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks